The Journal of Pediatrics
Volume 155, Issue 5 , Pages 612-617 , November 2009

Knowledge Gaps and Research Needs for Understanding and Treating Neonatal Hypoglycemia: Workshop Report from Eunice Kennedy Shriver National Institute of Child Health and Human Development

  • William W. Hay Jr., MD

      Affiliations

    • Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO
    • ,
  • Tonse NK. Raju, MD, DCH

      Affiliations

    • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
    • Corresponding Author InformationReprint requests: Tonse N. K. Raju, MD, DCH, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Blvd, Room 4B03, Bethesda, MD, 20892.
    • ,
  • Rosemary D. Higgins, MD

      Affiliations

    • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
    • ,
  • Satish C. Kalhan, MBBS, FRCP

      Affiliations

    • Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
    • ,
  • Sherin U. Devaskar, MD

      Affiliations

    • Department of Pediatrics, David Geffen School of Medicine, University of California Los Angeles & Mattel Children's Hospital UCLA, Los Angeles, CA

Received 23 March 2009 ,Revised 1 June 2009 ,Accepted 22 June 2009.

References 

  1. Cornblath M, Hawdon JM, Williams AF, et al. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics. 2000;105:1141–1145
  2. Termote B, Verswijvel G, Gelin G, Palmers Y. Neonatal hypoglycemic brain injury. JBR-BTR. 2008;91:116–117
  3. Inder T. How low can I go? The impact of hypoglycemia on the immature brain. Pediatrics. 2008;122:440–441
  4. Kwon KT, Tsai VW. Metabolic emergencies. Emerg Med Clin North Am. 2007;25:1041–1060
  5. Mitanchez D. Glucose regulation in preterm newborn infants. Horm Res. 2007;68:265–271
  6. Stanley CA. Hypoglycemia in the neonate. Pediatr Endocrinol Rev. 2006;4(Suppl 1):76–81
  7. Yalnizoglu D, Haliloglu G, Turanli G, et al. Neurologic outcome in patients with MRI pattern of damage typical for neonatal hypoglycemia. Brain Dev. 2007;29:285–292
  8. Alkalay AL, Flores-Sarnat L, Sarnat HB, et al. Plasma glucose concentrations in profound neonatal hypoglycemia. Clin Pediatr (Phila). 2006;45:550–558
  9. Filan PM, Inder TE, Cameron FJ, et al. Neonatal hypoglycemia and occipital cerebral injury. J Pediatr. 2006;148:552–555
  10. McGowan JE, Price-Douglas W, Hay WW. Glucose homeostasis. In:  Merenstein G,  Gardner S editor. Handbook of neonatal intensive care. 6th ed. St. Louis: Mosby Elsevier; 2006;p. 368–390
  11. Hawdon JM. Investigation and management of impaired metabolic adaptation presenting as neonatal hypoglycaemia. Paediatr Child Health. 2008;18:161–165
  12. Rozance PJ, Hay WW. Hypoglycemia in newborn infants: features associated with adverse outcomes. Biol Neonate. 2006;90:74–86
  13. Wight NE. Hypoglycemia in breastfed neonates. Breastfeed Med. 2006;1:253–262
  14. Williams AF. Neonatal hypoglycaemia: clinical and legal aspects. Semin Fetal Neonatal Med. 2005;10:363–368
  15. McGowan JE, Perlman JM. Glucose management during and after intensive delivery room resuscitation. Clin Perinatol. 2006;33:183–196
  16. Yager JY. Hypoglycemic injury to the immature brain. Clin Perinatol. 2002;29:651–674
  17. Deshpande S, Ward Platt M. The investigation and management of neonatal hypoglycaemia. Semin Fetal Neonatal Med. 2005;10:351–361
  18. Palladino AA, Bennett MJ, Stanley CA. Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem. 2008;54:256–263
  19. De Leon DD, Stanley CA. Mechanism of disease: advances in diagnosis and treatment of hyperinsulinism. Nat Clin Pract Endocrinol Metab. 2007;3:57–58
  20. Stanley CA, Baker L. The causes of neonatal hypoglycemia. N Engl J Med. 1999;340:1200–1201
  21. Giurgea I, Bellanné-Chantelot C, Ribeiro M, et al. Molecular mechanisms of neonatal hyperinsulinism. Hormone Res. 2006;66:289–296
  22. Fourtner SH, Stanley CA. Genetic and nongenetic forms of hyperinsulinism in neonates. NeoReviews. 2004;5:e370
  23. Glaser B. Hyperinsulinism of the newborn. Semin Perinatol. 2000;24:150–163
  24. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed. 2000;82:F79–F86
  25. Meissner T, Brune W, Mayatepek E. Persistent hyperinsulinaemic hypoglycaemia of infancy: therapy, clinical outcome and mutational analysis. Eur J Pediatr. 1997;156:754–757
  26. Shekhawat PS, Matern D, Strauss AW. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management. Pediatr Res. 2005;57:78R–86R
  27. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med. 1994;330:13
  28. Stanley CA, Hale DE. Genetic disorders of mitochondrial fatty acid oxidation. Curr Opin Pediatr. 1994;6:476
  29. Kahler SG. Metabolic disorders associated with neonatal hypoglycemia. NeoReviews. 2004;5
  30. Kalhan SC, D'Angelo L, Savin SM, Adam PAJ. Glucose production in pregnant women at term gestation: Sources of glucose for human fetus. J Clin Invest. 1979;63:388–394
  31. Marconi AM, Paolini C, Buscaglia M, et al. The impact of gestational age and fetal growth on the maternal-fetal glucose concentration difference. Obstet Gynecol. 1996;87:937–942
  32. Narkewicz MR, Carver TD, Hay WW. Induction of cytocolic phosphoenolpyruvate carboxykinase in the ovine fetal liver by chronic fetal hypoglycemia and hypoinsulinemia. Pediatr Res. 1993;33:493–496
  33. Rozance PJ, Limesand SW, Barry JS, et al. Chronic late gestation hypoglycemia up-regulates hepatic PEPCK associated with Increased PGC1α mRNA and pCREB in fetal sheep. Am J Physiol Endo Metab. 2007;294:E365–E370(E-00639-2007.R2)
  34. Srinivasan G, Pildes RS, Cattamanchi G, et al. Plasma glucose values in normal neonates: a new look. J Pediatr. 1986;109:114–117
  35. Hawdon JM, Ward Platt MP, Aynsley-Green A. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child. 1992;67:357–365
  36. Swenne I, Ewald U, Gustafsson J, et al. Inter-relationship between serum concentrations of glucose, glucagon and insulin during the first two days of life in healthy newborns. Acta Paediatr. 1994;83:915–919
  37. Kalhan S, Kiliç Ì. Carbohydrate as nutrient in the infant and child: range of acceptable intake. Eur J Clin Nutr. 1999;53:S94–S100
  38. Sunehag A, Ewald U, Larsson A, Gustafsson J. Glucose production rate in extremely immature neonates (<28 weeks) studied by use of deuterated glucose. Pediatr Res. 1993;33:97–100
  39. Denne SC, Kalhan SC. Glucose carbon recycling and oxidation in human newborns. Am J Physiol. 1986;251:E71–E77
  40. Sunehag A, Gustafsson J, Ewald U. Glycerol carbon contributes to hepatic glucose production during the first eight hours in health, term infants. Acta Paediatr. 1996;85:1339–1343
  41. Sunehag A, Ewald U, Gustafsson J. Extremely preterm infants (<28 weeks) are capable of gluconeogenesis from glycerol on their first day of life. Pediatr Res. 1996;40:553–557
  42. Kalhan SC, Parimi P, Van Beek R, et al. Estimation of gluconeogenesis in newborn infants. Am J Physiol. 2001;281:E991–E997
  43. Khan JY, Rajakumar RA, McKnight RA, et al. Developmental regulation of genes mediating murine brain glucose uptake. Am J Physiol. 1999;276:R892–R900
  44. Vannucci RC, Vannucci SJ. Glucose metabolism in the developing brain. Semin Perinatol. 2000;24:107–115
  45. Mantych GJ, Sotelo-Avila C, Devaskar SU. The blood-brain barrier glucose transporter is conserved in preterm and term newborn infants. J Clin Endocrinol Metab. 1993;77:46–49
  46. Mantych GJ, James DE, Chung HD, Devaskar SU. Cellular localization and characterization of GLUT3 glucose transporter isoform in human brain. Endocrinology. 1992;131:1270–1278
  47. Friedman JR, Thiele EA, Wang D, et al. Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet. Mov Disord. 2006;21:241–245
  48. Zovein A, Flowers-Ziegler J, Thamotharan S, et al. Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. Am J Physiol Regul Integr Comp Physiol. 2004;286:R273–R282
  49. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab. 2007;27:1766–1791
  50. Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics. 2008;122:65–74
  51. Salhab WA, Wyckoff MH, Laptook AR, Perlman JM. Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia. Pediatrics. 2004;114:361–366
  52. Martin S, Jensen R, Daly L, Jergenson C, Johnson MB, Buell T. Comparison of two methods of bedside blood glucose screening in the NICU: evaluation of accuracy and reliability. Neonatal Netw. 1997;16:39–43
  53. Bonacruz GL, Arnold JD, Leslie GI, et al. Survey of the definition and screening of neonatal hypoglycaemia in Australia. J Paediatr Child Health. 1996;32:299–301
  54. Aynsley-Green A, Hawdon JM. Hypoglycemia in the neonate: current controversies. Acta Paediatr Jpn. 1997;39(Suppl 1):S12–S16
  55. Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, Thompson M, Dunger DB. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed. 2005;90:F307–F310
  56. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Early insulin therapy in very-low-birth-weight infants. N Engl J Med. 2008;30(359):1873–1884
  57. Canadian Pediatric Society: Screening guidelines for newborns at risk for low blood glucose. Paediatr Child Health. 2004;9:723–729

 Editor's Note: The National Institutes of Health organizes focused workshops on topics that are in need of new clinical approaches or research. This article summarizes a workshop on neonatal hypoglycemia.

 —Alan H. Jobe, MD, PhD

 Funded by NICHD and NIH Office of Rare Diseases. Additional funding was received by The March of Dimes Foundation to the general NICHD gift fund. The American Academy of Pediatrics sponsored the travels of six speakers (none is the author) to this meeting. The study sponsors and co-funders were not involved on the conference agenda, discussions of materials, and interpretation of the presentations, the writing of the report, and the decision to submit the report for publications. The opinions expressed in this article are those of the author alone. They are not necessarily those of the US Department of Health and Human Services or of the National Institutes of Health, or of the co-sponsors. The authors declare no potential conflicts.

PII: S0022-3476(09)00613-1

doi: 10.1016/j.jpeds.2009.06.044

The Journal of Pediatrics
Volume 155, Issue 5 , Pages 612-617 , November 2009

Article Tools